Wilmington Savings Fund Society FSB acquired a new position in shares of Select Medical Holdings Co. (NYSE:SEM – Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 2,331 shares of the health services provider’s stock, valued at approximately $81,000.
A number of other large investors also recently made changes to their positions in SEM. GAMMA Investing LLC lifted its holdings in Select Medical by 16.6% during the third quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock worth $81,000 after acquiring an additional 330 shares during the period. Foster & Motley Inc. grew its position in Select Medical by 3.1% during the second quarter. Foster & Motley Inc. now owns 12,147 shares of the health services provider’s stock valued at $426,000 after buying an additional 370 shares during the period. KBC Group NV increased its holdings in Select Medical by 4.5% during the third quarter. KBC Group NV now owns 13,050 shares of the health services provider’s stock worth $455,000 after buying an additional 563 shares during the last quarter. Arizona State Retirement System raised its position in Select Medical by 2.0% in the second quarter. Arizona State Retirement System now owns 30,544 shares of the health services provider’s stock worth $1,071,000 after acquiring an additional 593 shares during the period. Finally, Swiss National Bank boosted its stake in Select Medical by 0.4% in the third quarter. Swiss National Bank now owns 215,900 shares of the health services provider’s stock valued at $7,528,000 after acquiring an additional 800 shares during the last quarter. 89.48% of the stock is owned by institutional investors.
Analyst Ratings Changes
SEM has been the subject of a number of recent research reports. StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a research report on Tuesday, December 3rd. Royal Bank of Canada boosted their price target on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Finally, Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th.
Select Medical Stock Performance
Shares of SEM opened at $19.06 on Friday. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The stock has a market capitalization of $2.47 billion, a price-to-earnings ratio of 8.91, a price-to-earnings-growth ratio of 0.39 and a beta of 1.43. Select Medical Holdings Co. has a 52-week low of $18.02 and a 52-week high of $40.98. The stock’s 50-day simple moving average is $29.79 and its 200 day simple moving average is $33.24.
Select Medical (NYSE:SEM – Get Free Report) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The company’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.46 earnings per share. Research analysts forecast that Select Medical Holdings Co. will post 1.97 EPS for the current fiscal year.
Select Medical Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th were paid a $0.125 dividend. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a yield of 2.62%. Select Medical’s dividend payout ratio is currently 23.36%.
Insider Buying and Selling at Select Medical
In other news, Director Marilyn B. Tavenner sold 32,000 shares of the stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the sale, the director now owns 22,000 shares of the company’s stock, valued at approximately $463,980. This represents a 59.26 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the sale, the vice president now directly owns 30,356 shares of the company’s stock, valued at $605,602.20. The trade was a 14.12 % decrease in their position. The disclosure for this sale can be found here. Insiders own 19.14% of the company’s stock.
About Select Medical
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Stories
- Five stocks we like better than Select Medical
- What Are Dividend Champions? How to Invest in the Champions
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- What is the S&P 500 and How It is Distinct from Other Indexes
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Investing in Travel Stocks Benefits
- 2 Underrated Quantum Computing Companies Starting to Rally
Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Co. (NYSE:SEM – Free Report).
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.